Sharing our stories
Follow us on social media

We look forward to share our latest updates and knowledge through our news and blog posts.

We will also constantly update the events we will attend.

Filter by

News Blog posts Events
Showing 10 stories
Apr. 2018 12 LEO Science & Tech Hub Enters Collaboration with Dina Katabi MIT, CSAIL to Explore the Use of Radio Signals for Quantification of Itch

LEO Science & Tech Hub, the Boston based R&D unit of LEO Pharma, has entered into a collaboration with Dina Katabi and MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL). Together they will explore the potential of the MIT group’s Emerald system to quantify scratching behavior. The Emerald technology uses the reflection of radio signals to measure human […]

Read more
Mar. 2018 09 Innovative Technologies Signal Bright Future for the Field of Dermatology

Revolutionary advancements continue to be made in the field of dermatology. At LEO Pharma, we are gaining exposure to many of these innovations on a daily basis. In recent months, we’ve had the opportunity to gain some extremely interesting market insights, in particular, at a recent panel discussion moderated by our VP, Peter Aksel Villadsen […]

Read more
Jan. 2018 05 SID and The LEO Pharma Research Foundation Awards

The Society for Investigative Dermatology (SID) and The LEO Foundation (LF) are pleased to announce a partnership for the IID 2018 Meeting in which a Gold and Silver Award will be presented. The IID 2018 Meeting is a joint Meeting of the European Society for Dermatological Research (ESDR), Japanese Society for Investigative Dermatology (JSID), and the […]

Read more
Oct. 2017 27 LEO Science & Tech Hub: Alopecia Areata Research

You can read about the blog from Follicle Thought on LEO Science & Tech Hub and out interest in Alopecia on the below link.  LEO Science & Tech Hub: Alopecia Areata Research

Read more
Oct. 2017 11 LEO Science & Tech Hub Announces a Collaboration with Elektrofi for Formulation Technology to Improve Dermatological Drug Delivery

LEO Science & Tech Hub, today announced a collaboration agreement with Elektrofi, a Cambridge-based biotechnology company focused on drug delivery innovations, to explore advanced formulation technology for dermatological drug delivery. “We are excited to announce this collaboration with Elektrofi to explore its innovative Elektroject™ process technology to increase our options in subcutaneous delivery of antibodies” […]

Read more
Sep. 2017 25 We will be at RESI Boston and at the Xconomy Awards on 26th September

The RESI conference takes place in San Francisco in January, in Toronto in April, in San Diego in June, in Boston in September, and in New York City in November. Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great […]

Read more
Sep. 2017 14 Are you at EADV? Come see us at booth 599

The LEO Science & Tech Hub is present at the EADV congress in Geneva. Please come and see our innovation booth where you will gain insights about the innovation ecosystem at LEO Pharma. We are there from 14th -16th September.

Read more
Aug. 2017 23 LEO Science & Tech Hub Announces Collaborations with MGH Wellman Center for Photomedicine to Explore Imaging Technology and Develop Microbiopsy Device

The Hub today announced two collaborative projects with The Wellman Center for Photomedicine at Massachusetts General Hospital. The Hub will provide research funding to support development of novel imaging technology with the laboratory led by Conor L. Evans, Ph.D., Assistant Professor, Harvard Medical School, and a disposable microbiopsy device with Walfre Franco, Ph.D., Instructor, and […]

Read more
Aug. 2017 10 LEO Science & Tech Hub is a finalist for the Newcomer category of Xconomy Awards

We are honored to announce that LEO Science & Tech Hub is a finalist for the Newcomer category of Xconomy Awards.

Read more
Jun. 2017 21 Novopyxis – The first start-up identified by LEO Science & Tech Hub

LEO Pharma announces an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical treatments in the skin.

Read more